| Product NDC: | 63323-970 |
| Proprietary Name: | BENZTROPINE MESYLATE |
| Non Proprietary Name: | BENZTROPINE MESYLATE |
| Active Ingredient(s): | 1 mg/mL & nbsp; BENZTROPINE MESYLATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-970 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA090233 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110531 |
| Package NDC: | 63323-970-02 |
| Package Description: | 5 VIAL in 1 BOX (63323-970-02) > 2 mL in 1 VIAL |
| NDC Code | 63323-970-02 |
| Proprietary Name | BENZTROPINE MESYLATE |
| Package Description | 5 VIAL in 1 BOX (63323-970-02) > 2 mL in 1 VIAL |
| Product NDC | 63323-970 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BENZTROPINE MESYLATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20110531 |
| Marketing Category Name | NDA |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | BENZTROPINE MESYLATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |